HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company with respect to the development and commercialization of two extended topical drug products. The products and terms of the agreement were not disclosed.
